Epigallocatechin-3-gallate ameliorates LPS-induced inflammation via the 67LRJAK2STAT3 signaling pathway数据2.zip

EGCG reduces the inflammatory response by inhibiting the JAK2/STAT3 signaling pathway by binding to the 67LR in MLE-12 cells.This study provides new insights for clinicians in treating patients with ARDS. On the basis of existing treatment regimens, it is advisable to consider combining EGCG or developing new drugs targeting its associated 67LR and the JAK2/STAT3 signaling pathway, which can enhance the anti-inflammatory effect and improve patients’prognosis. Meanwhile, it can also encourage people to prevent inflammatory-related diseases, including ARDS, through a reasonable diet.